Study design
This study was a prospective, parallel‐group, randomized, double‐blind, 8‐week trial. The Menoufia University Faculty of Medicine's ethical committee granted approval for this study (4/2021NEUR1), and it was carried out in accordance with the Declaration of Helsinki and its subsequent amendments. The study was registered at 